Cytosorbents Corp (CTSO) Live Share Price, Invest From India

Cytosorbents Corp Stock Performance

as on November 21, 2025 at 2:29 am IST

Day's Low
Day's High
$0.6
Day's Price Range
$0.65
$0.63
4.76%
Downside
3.17%
Upside
52 Week's Low
52 Week's High
$0.6
52-Week Price Range
$1.61
$0.63
4.76%
Downside
155.56%
Upside

Cytosorbents Corp share price movements today

Previous Close: $0.64
Open: $0.64
Volume: 1.0M
Day's Low - High: $0.6 - $0.65
52 Week Low - High: $0.6 - $1.61

Cytosorbents Corp Historical Returns

1 Month Return: -24.87 %
3 Month Return: -26.28 %
1 Year Return: -30.09 %
3 Year Return: -56.18 %
5 Year Return: -93.07 %

Cytosorbents Corp Stock Fundamentals & Key Indicators

Check Cytosorbents Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$39.1M

EPS (TTM)

-0.1367

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-12.7M

Revenue (TTM)

37.0M

Profit Margin

-27.77%

Return On Equity TTM

-93.26%

Cytosorbents Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cytosorbents Corp with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Cytosorbents Corp	BUY	$39.1M	-93.07%	NA	-27.77%
Boston Scientific Corp.	BUY	$143.8B	186.65%	51.88	14.43%
Stryker Corporation	BUY	$139.3B	54.81%	47.86	12.07%
Medtronic Plc	BUY	$128.7B	-9.81%	27.19	13.63%
Abbott Laboratories	BUY	$219.6B	11.8%	15.85	31.88%

See all

Stock Returns calculator for Cytosorbents Corp Stock including INR - Dollar returns

The Cytosorbents Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Cytosorbents Corp investment value today

Current value as on today

₹75,957

Returns

₹24,043

(-24.04%)

Returns from Cytosorbents Corp Stock

₹29,213 (-29.21%)

Dollar Returns*

₹5,171 (+5.17%)

Analyst Recommendation on Cytosorbents Corp Stock

Based on 9 analysts

BUY

77.78%

Buy

22.22%

Hold

0.00%

Sell

Based on 9 analysts, 77.78% of analysts recommend a 'BUY' rating for Cytosorbents Corp. Average target price of $5.25

Cytosorbents Corp Share Price Target

Get share price movements and forecasts by analysts on Cytosorbents Corp.

What analysts predicted

88%UPSIDE

Target Price

$5.25

Current Price

$0.63

Analyzed by

9 Analysts

Target

$5.25

Cytosorbents Corp target price $5.25, a slight upside of 88% compared to current price of $0.63. According to 9 analysts rating.

Cytosorbents Corp Stock’s Investor Sentiment and Interest

Search interest for Cytosorbents Corp Stock has increased by 86% in the last 30 days, reflecting an upward trend in search activity.

Time period: October 22, 2025 to November 21, 2025

Change:86% versus previous 30 day period

Cytosorbents Corp Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	8	7	7	8	8	8	9	8	9	9
Gross Profit	4	4	5	6	6	4	9	6	6	6
Operating Income	-6	-7	-9	-4	-3	-4	-4	-3	-3	-2
EBITDA	-6	-8	-6	-5	-2	-1	-8	-3	-3	-2
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-6	-9	-6	-6	-4	-2	-9	-1	1	-3
Income Tax Expense	0	0	0	0	0	-	-1	-	-	0
Net Income	-6	-9	-5	-6	-4	-2	-7	-1	1	-3
Net Profit Margin	-76.23%	-118.57%	-79.41%	-70.73%	-46.86%	-27.10%	-86.16%	-16.94%	20.25%	-33.42%

Cytosorbents Corp Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	4	8	13	20	22	39	40	34	31	35
Gross Profit	1	4	7	12	15	28	29	20	21	25
Operating Income	-9	-11	-9	-15	-18	-10	-22	-31	-31	-16
EBITDA	-9	-11	-8	-15	-18	-9	-21	-30	-27	-15
Interest Expense	0	0	0	1	1	1	3	0	0	1
Depreciation	-	-	0	0	0	0	1	1	2	1
Income Before Tax	-8	-12	-9	-17	-20	-8	-25	-33	-30	-22
Income Tax Expense	0	0	0	0	-1	-1	0	-1	0	-1
Net Income	-8	-11	-8	-17	-19	-7	-24	-32	-29	-20
Net Profit Margin	-200.50%	-145.49%	-63.23%	-84.98%	-84.63%	-19.86%	-61.23%	-94.59%	-94.09%	-58.21%

Cytosorbents Corp Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-9	-5	-6	-4	-2	-7	-1	1	-3
Operating Cash Flow	-5	-6	-4	-4	-2	-2	-3	-1	-2
Investing Cash Flow	0	0	0	0	0	0	0	0	-
Financing Cash Flow	0	12	0	9	0	0	6	0	-
Change in Cash	-4	5	-5	4	-2	-2	3	-1	-2

Cytosorbents Corp Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-11	-8	-17	-19	-7	-24	-32	-28	-20
Operating Cash Flow	-6	-6	-10	-16	-5	-14	-28	-21	-14
Investing Cash Flow	1	-1	-1	-1	-1	-4	-6	0	0
Financing Cash Flow	5	20	17	8	66	0	4	14	9
Change in Cash	0	12	5	-10	59	-17	-29	-8	-5

Global Institutional Holdings in Cytosorbents Corp

Funds	Holdings
Avenir Corporation	8.06%
Skylands Capital, LLC	4.17%
Vanguard Group Inc	3.39%
Neuberger Berman Group LLC	2.54%
CM Management, LLC	1.99%

See all

Insights on Cytosorbents Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Boston Scientific Corp. has given 16.1% return, outperforming this stock by 71.1%
NO EFFECT
Against Peers
In the last 1 year, Edwards Lifesciences Corp. has given 22.2% return, outperforming this stock by 50.4%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 9.61M → 9.48M (in $), with an average decrease of 1.4% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 1.94M → -3.17M (in $), with an average decrease of 262.8% per quarter
NEGATIVE IMPACT
Price Dip
In the last 1 month, CTSO stock has moved down by -22.9%

About Cytosorbents Corp

cytosorbents (nasdaq: ctso) cytosorbents corporation is a leader in critical care immunotherapy, specializing in blood purification. its flagship product, cytosorb® is approved in the european union with distribution in 40 countries around the world, as a safe and effective extracorporeal cytokine adsorber, designed to reduce the "cytokine storm" or "cytokine release syndrome" that could otherwise cause massive inflammation, organ failure and death in common critical illnesses such as sepsis, burn injury, trauma, lung injury and pancreatitis, as well as in cancer immunotherapy. these are conditions where the risk of death is extremely high, yet no effective treatments exist. cytosorb® is also being used during and after cardiac surgery to remove inflammatory mediators, such as cytokines and free hemoglobin, which can lead to post-operative complications, including multiple organ failure. cytosorbents' purification technologies are based on biocompatible, highly porous polymer beads

Organisation	Cytosorbents Corp
Headquarters	305 College Road East, Princeton, NJ, United States, 08540
Industry	Health Technology
CEO	Dr. Phillip P. Chan M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Cytosorbents Corp

Name	Title
Mr. Vincent J. Capponi M.S.	President & COO
Ms. Kathleen P. Bloch CPA, M.B.A.	Advisor
Mr. Christopher Cramer M.B.A., M.S.	Senior Vice President of Business Development
Jodi Hoover	Executive
Dr. Phillip P. Chan M.D., Ph.D.	CEO & Director
Mr. Peter J. Mariani CPA	Chief Financial Officer
Dr. Efthymios N. Deliargyris FACC, FESC, FSCAI, M.D.	Chief Medical Officer
Dr. Christian Steiner M.D.	Executive Vice President of Sales & Marketing
Dr. Robert H. Bartlett M.D.	Co-Chairman of Cardiac Surgery Advisory Board & Consultant

FAQs

What is Cytosorbents Corp share price today?

Cytosorbents Corp share price today is $0.63 as on November 21, 2025 at 2:29 am IST at the close of the market. Cytosorbents Corp share today touched a day high of $0.65 and a low of $0.6.

What is the 52 week high and 52 week low for Cytosorbents Corp share?

Cytosorbents Corp share touched a 52 week high of $1.61 on February 14, 2025 and a 52 week low of $0.6 on November 20, 2025. Cytosorbents Corp stock price today i.e. November 21, 2025 at 2:29 am IST is closed at $0.63,which is 60.87% down from its 52 week high and 5.00% up from its 52 week low.

What is Cytosorbents Corp's market capitalisation today?

Cytosorbents Corp market capitalisation is $0.00T as on November 21, 2025 at 2:29 am IST.

How to invest in Cytosorbents Corp Stock (CTSO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cytosorbents Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cytosorbents Corp Shares that will get you 2.3810 shares as per Cytosorbents Corp share price of $0.63 per share as on November 21, 2025 at 2:29 am IST.

What is the minimum amount required to buy Cytosorbents Corp Stock (CTSO) from India?

Indian investors can start investing in Cytosorbents Corp (CTSO) shares with as little as ₹88.68 or $1 (as of November 21, 2025 at 9:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹886.80 in Cytosorbents Corp stock (as per the Rupee-Dollar exchange rate as on November 21, 2025 at 9:37 am IST). Based on Cytosorbents Corp share’s latest price of $0.63 as on November 21, 2025 at 2:29 am IST, you will get 15.8730 shares of Cytosorbents Corp. Learn more about fractional shares .

What are the returns that Cytosorbents Corp has given to Indian investors in the last 5 years?

Cytosorbents Corp stock has given -93.07% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?